William Pearse

2PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 02, 2021
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas.

William B Pearse, Adam M Petrich, Leo I Gordon

Pageof 1

Frequent Collaborators

1 joint publications

Jason B Kaplan